Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma

Renal medullary carcinoma (RMC) is an extremely rare and aggressive form of kidney cancer. It is almost exclusively found in young people who carry the sickle cell gene. The sickle cell gene is particularly common in people with an African or Caribbean family background and can cause a group of inherited conditions that affect the red blood […]

read more

ASCO GU 2019: Gemcitabine plus axitinib in patients with sarcomatoid renal cell carcinoma (RCC)

Results from this trial for sarcomatoid renal cell carcinoma (RCC) patients were reported at the American Society of Clinical Oncology (ASCO) genitourinary (GU) conference held in San Francisco in February 2019. Because there are limited treatment options for this aggressive form of RCC, the trial was designed to verify anecdotal reports of good responders to […]

read more
Showing all 2 results